Meanwhile, they found that the combination of BMP-9 and anti-VEGF drugs could alleviate the possible adverse effects of anti-VEGF alone and may serve as a new direction for the treatment of AMD in the future [126]. This evidence concerns the gene VEGFA and age-related macular degeneration.